ArticleDiscover oncology2024

Targeting the insulin-like growth factor-1 receptor to overcome imatinib resistance in chronic myeloid leukemia.

Seiichi Okabe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.